1-6 of 6
Zhiya Yu
Close
Sort by
Journal Articles

Developing the Next Generation of iPSC Cell-Based Immunotherapies

Raul Vizcardo, PhD, Nicholas Donald Klemen, MD, Rafiqul Islam, PhD, Devikala Gurusamy, PhD, Naritaka Tamaoki, MD, PhD, Li Jia, PhD, Zhiya Yu, PhD, Amanda N Hennings, PhD, Takuya Maeda, MD, Marta Bosch-Marce, PhD, Meghan L Good, MD, Svetlana Pack, PhD, David F. Stroncek, Francis A Flomerfelt, PhD, Michael J Kruhlak, PhD, Nicholas Phillip Restifo, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3707.
https://doi.org/10.1182/blood-2018-99-118593
Published: 2018
Journal Articles

Human effector CD8 + T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy

Christian S. Hinrichs, Zachary A. Borman, Luca Gattinoni, Zhiya Yu, William R. Burns, Jianping Huang, Christopher A. Klebanoff, Laura A. Johnson, Sid P. Kerkar, Shicheng Yang, Pawel Muranski, Douglas C. Palmer, Christopher D. Scott, Richard A. Morgan, Paul F. Robbins, Steven A. Rosenberg, Nicholas P. Restifo
Journal: Blood
Blood (2011) 117 (3): 808–814.
https://doi.org/10.1182/blood-2010-05-286286
Published: 2011
Includes: Supplemental data
Journal Articles

Th17-Derived Memory Cells Are Long-Lived and Retain a Stem-Like Molecular Signature

Pawel Muranski, MD, Zachary Borman, Sid Kerkar, Yun Ji, Luca Gattinoni, MD, Reger N Robert, Luis Sanchez-Perez, Klebanoff A Christopher, Zhiya Yu, Kern J Steven, Gabriela Ferreyra, Robert L Danner, Nicholas P Restifo
Journal: Blood
Blood (2010) 116 (21): 1018.
https://doi.org/10.1182/blood.V116.21.1018.1018
Published: 2010
Journal Articles

Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells

James N. Kochenderfer, Zhiya Yu, Dorina Frasheri, Nicholas P. Restifo, Steven A. Rosenberg
Journal: Blood
Blood (2010) 116 (19): 3875–3886.
https://doi.org/10.1182/blood-2010-01-265041
Published: 2010
Includes: Supplemental data
Journal Articles

IL-17A-Expressing CD4+ T Cells Must Acquire the Expression of T-Bet and IFN-γto Destroy Tumor Cells In Vivo.

Pawel Muranski, MD, Sid P Kerkar, Zachary A Borman, Robert Reger, Luis Sanchez-Perez, Christian S Hinrichs, Zhiya Yu, Douglas C Palmer, Luca Gattinoni, Nicholas P. Restifo
Journal: Blood
Blood (2009) 114 (22): 468.
https://doi.org/10.1182/blood.V114.22.468.468
Published: 2009
Journal Articles

Programming tumor-reactive effector memory CD8 + T cells in vitro obviates the requirement for in vivo vaccination

Christopher A. Klebanoff, Zhiya Yu, Leroy N. Hwang, Douglas C. Palmer, Luca Gattinoni, Nicholas P. Restifo
Journal: Blood
Blood (2009) 114 (9): 1776–1783.
https://doi.org/10.1182/blood-2008-12-192419
Published: 2009
Includes: Supplemental data